What to make of President Trump’s executive order targeting direct-to-consumer pharma marketing. The White House aims to do this by sending out warning letters and cease and desist orders to pharma companies who engage in “misleading” ad practices. (MM+M)
Just a quarter of Americans think that recent recommendations for fewer vaccines from the Trump administration were based on scientific evidence and facts. The administration has signaled that pregnant women and healthy teens should not get COVID-19 vaccine shots. (Reuters)
Melinda French Gates announced a $100 million investment in women’s health research. Her organization, Pivotal, will partner with NGOs to address maternal mortality, mental health and cardiovascular diseases in women. (ABC News)
A recent report from Morningstar indicated that U.S. tariffs on pharmaceutical products should be manageable for pharma companies. The pricing risk for pharma companies to reduce drug prices is “exceedingly low”, the report finds. (U.S. World News and Reports)
In a bid to slash costs, Novo Nordisk is cutting 9,000 jobs. The job cuts amount to approximately 11% of its global workforce. (CNN)
To read yesterday’s edition of Five things for pharma marketers to know, click here.